Its localization in the tumor surface, key metabolic functions, and ability to promote tumor aggressive properties could be exploited for the development of novel comprehensive cancer care modalities that combine ENO1 surface imaging with targeted therapeutic interventions. This evidence concerns the gene ENO1 and neoplasm.